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Field hospital for ﬂuid intake: The solution for the
decrease mortality in dengue fever
D. Borghi ∗, M.D. Canetti, W. Braz, L. Cortes, R.C. Vascon-
cellos
Military Fire Corps, Rio de Janeiro, Brazil
Background: December 2007, some cases of dengue hem-
orrhagic fever were diagnosed in clildren in Rio de Janeiro,
Brazil. Along the following months, the has ravaged the
state, infecting more than 150,000 people with 232 sus-
pected deaths. 42% of fatal cases were in children. The
deaths showed us that the plasma leakage and shock are
more common than hemorrhagic phenomena. In many cases,
the presence of pleural, pericardial and peritoneal effu-
sions were associated with a severe disease. The emergency
rooms in the state were not capableto absorb the extra
demand and causing the collapse of the healthcare system.
The last outbreak in Rio de Janeiro was happen in 2002 with
the serotype 3 and now the serotype 2 e 3 has been reported.
Methods: On February 2008, a hundred of new dengue
cases were being reported/ hour, so the health depart-
ment of Rio the Janeiro State, the Mylitary Fire Corps and
the Armed Forces assembled 7 ﬁeld hospitals to support
the emergency rooms, working with more 1000 health care
providers. The average ﬁeld hospital was equipped with
an electronic blood cell counting machine, 30 beds for
hydratation and 1 advanced ambulance. This intervention
was based in the cocept of disaster medicine. The patients
were triaged in the hospitals, had their blood taken for
diagnosis, kept in observation and hydratated. The caes
with deterioration were admitted to the hospital and if the
patient got better, he was sent home.
Results: The intravenous ﬂuid administration during 12
hour observation period was associated with a decreased
risk for the death and complications. On April, 29,000 cases
were treated in the ﬁeld hospitals and less than 2% of the
patients were admitted to the emergency hospitals.
Conclusion: The Field hospitals were a practical solution
to reduce the mortality and morbility in this outbreak.
doi:10.1016/j.ijid.2010.02.1587
24.003
Utility of dengue antigen-capture ELISA in the diagnosis
of dengue Fever in the real world
S. Kalimuddin ∗, H.N. Leong, X.L. Bai, S.H. Lim, K.P. Chan
Singapore General Hospital, Singapore, Singapore
Background: Dengue fever is an endemic and potentially
fatal viral infection threatening more than 2.5 million peo-
ple in over 100 regions around the world - hence the need for
timely and accurate diagnosis using an easy and affordable
assay.
Methods: In our study, the use of a commercial dengue
antigen-capture ELISA (PLATELIA DENGUE NS1 AG by Bio-
Rad) was evaluated to demonstrate its usefulness in
diagnosing acute dengue viral infection in an acute tertiary
centre in Singapore. Our country is endemic for dengue fever
with more than 7000 cases reported in 2008. Retrospec-
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ive analysis was performed on 197 patients in whom serum
engue antigen-capture ELISA was carried out. The diagno-
is of dengue was made based on dengue IgM positivity and
he presence of classic clinical features of dengue fever.
Results: A total of 75 patients were identiﬁed to have
engue fever. The overall sensitivity of dengue antigen-
apture ELISA was 64% (48/75). Sensitivity was 81.5% when
esting was carried out on serum samples taken during Day
to 4 of fever, 59.4% during Day 5-6 and 42.9% during Day 7-
. In patients who did not have dengue fever, the speciﬁcity
as 100%.
Conclusion: The results suggest that the dengue antigen-
apture ELISA is most useful in the diagnosis of dengue fever
ithin the ﬁrst 4 days of fever.
oi:10.1016/j.ijid.2010.02.1588
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peciﬁc point mutations in the envelope protein of
ick-borne encephalitis virus enhance non-viraemic
ransmission efﬁciency in a tick vector
. Khasnatinov1,∗, K. Ustanikova2, T.V. Frolova3, V.V.
ogodina3, N.G. Bochkova3, L.S. Levina3, M. Slovak4, M.
azimirova4, M. Labuda4, B. Klempa2, E. Eleckova2, E.A.
ould5, T.S. Gritsun6
SC FHHR SD RAMS, Irkutsk, Russian Federation
Institute of Virology, Slovak Academy of Sciences,
ratislava, Slovakia
Chumakov Institute of Poliomyelitis and Viral Encephali-
ides RAMS, Moscow, Russian Federation
Institute of Zoology, Slovak Academy of Sciences,
ratislava, Slovakia
Centre for Ecology and Hydrology Oxford, NERC, Oxford,
nited Kingdom
The University of Reading, Reading, United Kingdom
Background: Tick-borne encephalitis virus (TBEV) is
ransmitted to humans by Ixodid ticks causing >10,000 cases
f disease annually. The risk of human infection relates to
he efﬁciency of virus transmission between infected and
ninfected ticks. Here we identify speciﬁc mutations in the
iral envelope protein that affect transmission efﬁciency of
BEV between ticks.
Methods: The genomes of 4 ﬁeld isolates of TBEV deﬁ-
ient in haemagglutination, were sequenced and recreated
y site-directed mutagenesis, in a TBEV infectious clone.
hey were then compared with the wild-type infectious
lone in mice, porcine kidney PS cells and adult and nymphal
. ricinus ticks.
Results: Sequence analysis revealed unique amino acid
ubstitutions D67G, E122G or D277A in the envelope glyco-
rotein. Each mutation resulted in an increase of net charge
nd hydrophobicity on the virion surface. When introduced
ndividually into the TBEV infectious clone (IC), each sub-
titution inhibited haemagglutination and reduced mouse
euroinvasiveness from 65% to 15-30%. Antibody produc-
ion in infected mice was 1.5-3 times lower for IC-E122G
nd IC-D277A suggesting lower levels of viraemia and/or
eﬁcient immune stimulation induced by these viruses. All
utants demonstrated delayed growth in PS cells during the
rst 24hpi; however, mutant IC-D67G exhibited signiﬁcantly
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etter growth characteristics than IC-E122G and IC-D277A.
he reproduction of IC-E122G and IC-D277A in fasting ticks
as similar to that of control HA positive virus whereas
he titres of IC-D67G were signiﬁcantly lower (2.5-3 vs. 1-2
og10PFU/ml, respectively). In feeding ticks, the titre of IC-
122G increased approximately 1000-fold and IC-D277A and
C-D67G - approximately 300-fold, whereas for control virus
he increase was about 10-fold. Non-viraemic transmission
fﬁciency from infected to uninfected ticks was increased
y each individual substitution in nymphal I. ricinus (Figure
).
igure 1 Tick-to-tick transmission rate (clear bars) is
xpressed as the proportion of infected I.ricinus nymphs.
lack triangles show the average virus titres in individu-
lly infected recipient nymphs as determined by plaque
ssay.
Conclusion: We hypothesize that the mechanism
f adaptation of TBEV to its host utilizes the shift of
harge/hydrophobicity at several critical aminoacid
esidues exposed on the virion surface. This shift results in
ifferent biological consequences depending on the local-
sation of certain aminoacid residue. The results provide
aluable information concerning the maintenance in nature
nd the emergence of pathogenic variants of TBEV.
oi:10.1016/j.ijid.2010.02.1589
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pre-exposure prophylactic for arenaviral hemorrhagic
ever in the pirital virus-Syrian golden hamster model
. Vela ∗, R. Stammen, J. Garver, S. Sarrazine
Battelle, Columbus, OH, USA
Background: Arenaviral infections in humans have the
apacity to lead to hemorrhagic fever and may be fatal.
upportive care and ribavirin remain the only options for
renaviral infections in humans; however, treatment is often
neffective because of the time frame before the disease is
ecognized. Pirital virus (PIRV) is a New World arenavirus
hat was isolated from the cotton rat (Sigmodon alstoni) in
he Municipality of Guanarito, Portuguesa State, Venezuela
n 1994. This virus is not associated with any form of disease
n humans and can be studied in a biosafety level 3 (BSL-
) laboratory environment; therefore, the development of
small animal model system is ideal for testing and/or
creening of vaccines and therapeutics against arenavirus
emorrhagic fever.
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Methods: Treated andmock-treated female Syrian golden
mplanted with telemetry units measuring temperature and
ctivity, were utilized to test the antiviral effects of the
ompound named BAT-V1. The animals were followed for
4 days post-challenge. Clinical signs of disease were mon-
tored. Temperatures and acitivty levels were recorded by
elemetry. Clinical chemistry, hematology, and coagulation
arameters were measured and viral titers in the tissues and
lood were analyzed.
Results: We demonstrate that PIRV infection in Syrian
olden hamsters leads to morbidity, fever, lethargy, hem-
rrhagic fever manifestations, viremia, and replication in
elect tissues and results in 100% mortality within 8 days
fter challenge. Treating hamsters with BAT-V1 prior to chal-
enge signiﬁcantly protected the animals from death, which
s important because survival of hamsters infected with PIRV
as not previously been reported. Abnormal temperatures,
ematology, clinical chemistry, and coagulation parameters
ssociated with PIRV infection in hamsters all rebounded to
ormal levels in the treated animals. Lower viremia and inhi-
ition of viral replication in select tissues were also observed
n treated animals when compared to mock-treated animals.
Conclusion: Results from this study demonstrate a BSL-
arenaviral hemorrhagic fever animal model that can be
tilized to test and screen multiple antivirals in a time
fﬁcient and cost effective manner. Additionally, the data
emonstrate pre-exposure protective efﬁcacy of an antiviral
gainst PIRV-induced hemorrhagic fever in the Syrian golden
amster model.
oi:10.1016/j.ijid.2010.02.1590
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haracterization of a novel neutralizing monoclonal
ntibody that recognizes the fusion loop of Flavivirus
nvelope protein
. Deng1, G. Ji 2, Y. Kang2, T. Jiang1, J. Dai2, E. Qin1, Y.
uo2, C. Qin1,∗
Beijing Institute of Microbiology and Epidemiology, Bei-
ing, China
International Joint Cancer Institute, Second Military Med-
cal University, Shanghai, China
Background: Dengue, West Nile and yellow fever viruses
re major human pathogens that belong to the Flavivirus
enus, and cause large epidemics and deaths worldwide.
iven the lack of approved antiviral treatment, recombi-
ant monoclonal antibodies (MAbs) have been veriﬁed as
andidate for the treatment of ﬂavivirus infections.
Methods: A panel of MAbs against dengue 2 virus was
roduced according to the standard procedure. Indirect
mmunoﬂuorescence assay and ELISA were performed to
dentify the cross-reactivity against ﬂaviviruses. In vitro
ndin vivo experiments were performed to analyze the neu-
ralizing and protection proﬁles of a selected MAb against
engue and other ﬂavivirus. Epitope mapping and in vitro
inding inhibition assays were further carried out to charac-
erize this speciﬁc MAb.
Results: Plaque reduction neutralization test demon-
trated that MAb 2A10G6 was active to neutralize dengue
-4, yellow fever and West Nile viruses. In vivo protection
